These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27035234)
41. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients. Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679 [TBL] [Abstract][Full Text] [Related]
43. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease. Zhao M; Maani N; Dowling JJ Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359 [TBL] [Abstract][Full Text] [Related]
44. [Clinical and biopsy-based myopathological features of 5 cases with centronuclear myopathy]. Li HH; Liu SP; Li W; Zhao YY; Wu JL; Li DN; Yan CZ Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):856-9. PubMed ID: 19099905 [TBL] [Abstract][Full Text] [Related]
45. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685 [TBL] [Abstract][Full Text] [Related]